Mitochondrial complex I deficiency induces Alzheimer's disease–like signatures that are reversible by targeted therapy
2025 · Alzheimer s & Dementia · 8 citations
https://doi.org/10.1002/alz.70519
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
45
Citations
2
h-index
1
i10-index
Mark Ostroot is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Alzheimer's disease research and treatments & Mitochondrial Function and Pathology & Neuroscience and Neuropharmacology Research. The author has an h-index of 2, co-authored 12 publications.
ORCID: 0009-0009-1253-2120https://doi.org/10.1002/alz.70519
https://doi.org/10.1016/j.ebiom.2025.105924
Click to start Chat